Wellstar International, Inc. Secures $250,000 of New Financing
March 09 2009 - 6:00AM
Marketwired
Wellstar International, Inc. (OTCBB: WLSI), a provider of
specialized diagnostic software and equipment, announced today that
it has secured $250,000 in financing through a private transaction
with an accredited private investor. The financing will provide the
Company adequate initial funding to start the roll-out of its
thermal imaging systems that detect early signs of pressure ulcers
among patients that are bed-ridden. However, the Company will need
additional capital to implement its first installations, in which
the Company is in final stages of agreement with private equity
firm, Fairhills Capital, who earlier this week signed a LOI for up
to $1 Million in equity funding.
Wellstar's CEO John Antonio stated, "We are pleased with the
confidence that our newest investor has placed in our ability to
reach our next milestone. Through our innovative thermal imaging
systems, Wellstar will become the leader in early detections of
pressure ulcers throughout the healthcare industry. Our goal is
simple; we want to provide the healthcare industry with a critical
tool that will help them save lives and curtail potential liability
by simply detecting the pressure ulcers before its outbreak."
The company has developed its thermal imaging system for various
applications. The TMI technology and software has been approved by
the FDA as an Adjunctive Diagnostic Screening Procedure for early
breast cancer detection, differential diagnoses of pain
dysfunctions (such as Reflex Sympathetic Dystrophy, Neuromuscular
Skeletal Syndromes and neurological disorders), for the early
detection of pressure ulcers, deep tissue injuries, and bedsores,
as well as for orthopedic applications. The company has plans to
market diagnostic systems for all of the above mentioned
applications.
ABOUT WELLSTAR INTERNATIONAL, INC.
Wellstar International, Inc., through its wholly owned operating
subsidiary Trillenium Medical Imaging, Inc. (TMI), is poised to
become a leading diagnostic company in the healthcare industry. TMI
has developed and is marketing fully calibrated and functional,
thermal imaging systems that utilize state-of-the-art infrared
technologies and proprietary software to accurately and
cost-effectively measure physiological changes in the human body.
More information on the Company and its unique diagnostic software
and product line is available on Wellstar's corporate Website by
visiting: www.wellstar.us
FORWARD-LOOKING STATEMENTS
This press release contains statements, which may constitute
'forward-looking statements' within the meaning of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended by
the Private Securities Litigation Reform Act of 1995. Prospective
investors are cautioned that any such forward-looking statements
are not guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from
those contemplated by such forward-looking statements. Important
factors currently known to management that could cause actual
results to differ materially from those in forward-statements
include fluctuation of operating results, the ability to compete
successfully and the ability to complete before-mentioned
transactions. The company undertakes no obligation to update or
revise forward-looking statements to reflect changed assumptions,
the occurrence of unanticipated events or changes to future
operating results.
Contact: Equiti-trend Advisors LLC (800) 953-3350 Toll-Free,
U.S. & Canada (858) 436-3350 Local or International
Wellstar (CE) (USOTC:WLSI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Wellstar (CE) (USOTC:WLSI)
Historical Stock Chart
From Sep 2023 to Sep 2024